Advanced Enzyme Technologies Ltd
Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on September 01, 2026.
BUYBACK
▲ Positive Development
LOW RISK
📅 Filed on BSE: 01 Sep 2026, 06:11 PM IST · BSE ID: 7d6a6887-8b92-4565-92c7-4f98387d290e
View Original BSE Filing (PDF)
💡
In Simple Terms
The company bought back a portion of its own shares from the open market on September 1st.
🤖 AI Summary
- Advanced Enzyme Technologies bought 58,774 shares on September 1, 2026.
- Shares were repurchased via stock exchange mechanism under buyback regulations.
- The average acquisition price per share was ₹296.0490.
- Total buyback count is now 883,802 shares as of September 1, 2026.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Equity Shares bought back on September 01, 2026
58,774
Average Price of acquisition
296.0490
Cumulative Equity Shares bought as on September 01, 2026
8,83,802
🏢 How This Affects the Company
The buyback reduces the total number of outstanding equity shares, potentially increasing earnings per share for remaining shareholders.
Share buybacks can signal management's confidence in the company's valuation and may reduce overall share count, impacting shareholder metrics.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding this buyback activity.
👤
Who Is Affected
Shareholders who sold shares in the open market on September 1, 2026, were directly involved in the buyback.
🔍
Management Signal
The continued execution of the buyback program signals management's intent to return capital to shareholders and manage outstanding share count.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Subsequent daily buyback reports from the company.
Updates on total shares repurchased against the buyback target.
Company's next quarterly results announcement for financial performance.
LOW RISK
This filing is a routine disclosure on buyback execution, with no inherent new risks.
💡 Investor Takeaway
Advanced Enzyme Technologies repurchased 58,774 shares on September 1, 2026, at an average price of ₹296.0490, bringing the total buyback to 883,802 shares.
⚖️ Strengths & Concerns
✅ Positives
- Completed buyback of 58,774 equity shares on September 1, 2026, adding to buyback program.
- Average acquisition price of ₹296.0490 per share on September 1, 2026, reported excluding transaction costs.
❓ Frequently Asked Questions
How many shares did Advanced Enzyme Technologies buy back on September 1, 2026?
Advanced Enzyme Technologies bought back 58,774 equity shares on September 1, 2026.
What was the average acquisition price per share on September 1, 2026?
The average price of acquisition for shares bought on September 1, 2026, was ₹296.0490.
What is the total number of shares bought back by Advanced Enzyme Technologies so far?
As of September 1, 2026, the total cumulative equity shares bought back by Advanced Enzyme Technologies is 8,83,802.
Through which mechanism were the shares bought back?
The shares were bought back from the open market through the stock exchanges mechanism.
Questions based on this BSE filing only. For information purposes.